Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations.
Beltrand J, Elie C, Busiah K, Fournier E, Boddaert N, Bahi-Buisson N, Vera M, Bui-Quoc E, Ingster-Moati I, Berdugo M, Simon A, Gozalo C, Djerada Z, Flechtner I, Treluyer JM, Scharfmann R, Cavé H, Vaivre-Douret L, Polak M; GlidKir Study Group. Beltrand J, et al. Among authors: berdugo m. Diabetes Care. 2015 Nov;38(11):2033-41. doi: 10.2337/dc15-0837. Epub 2015 Oct 5. Diabetes Care. 2015. PMID: 26438614 Clinical Trial.
Erratum. Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations. Diabetes Care 2015;38:2033-2041.
Beltrand J, Elie C, Busiah K, Fournier E, Boddaert N, Bahi-Buisson N, Vera M, Bui-Quoc E, Ingster-Moati I, Berdugo M, Simon A, Gozalo C, Djerada Z, Flechtner I, Treluyer JM, Scharfmann R, Cavé H, Vaivre-Douret L, Polak M; GlidKir Study Group. Beltrand J, et al. Among authors: berdugo m. Diabetes Care. 2016 Jan;39(1):175. doi: 10.2337/dc16-er01. Diabetes Care. 2016. PMID: 26696658 No abstract available.
Glibenclamide oral suspension: Suitable and effective in patients with neonatal diabetes.
Beltrand J, Baptiste A, Busiah K, Bouazza N, Godot C, Boucheron A, Djerada Z, Gozalo C, Berdugo M, Tréluyer JM, Elie C, Polak M; GLID-KIR study group. Beltrand J, et al. Among authors: berdugo m. Pediatr Diabetes. 2019 May;20(3):246-254. doi: 10.1111/pedi.12823. Epub 2019 Feb 21. Pediatr Diabetes. 2019. PMID: 30684309 Clinical Trial.
The antidiabetic drug glibenclamide exerts direct retinal neuroprotection.
Berdugo M, Delaunay K, Naud MC, Guegan J, Moulin A, Savoldelli M, Picard E, Radet L, Jonet L, Djerada Z, Gozalo C, Daruich A, Beltrand J, Jeanny JC, Kermorvant-Duchemin E, Crisanti P, Polak M, Behar-Cohen F. Berdugo M, et al. Transl Res. 2021 Mar;229:83-99. doi: 10.1016/j.trsl.2020.10.003. Epub 2020 Oct 17. Transl Res. 2021. PMID: 33080394 Free article.
Neonatal Diabetes Mellitus.
Beltrand J, Busiah K, Vaivre-Douret L, Fauret AL, Berdugo M, Cavé H, Polak M. Beltrand J, et al. Among authors: berdugo m. Front Pediatr. 2020 Sep 30;8:540718. doi: 10.3389/fped.2020.540718. eCollection 2020. Front Pediatr. 2020. PMID: 33102403 Free PMC article. Review.
Early treatment of neonatal diabetes with oral glibenclamide in an extremely preterm infant.
Galderisi A, Kermorvant-Duchemin E, Daruich A, Bonnard AA, Lapillonne A, Aubelle MS, Perrella B, Vial Y, Cave H, Berdugo M, Jarreau PH, Polak M, Beltrand J. Galderisi A, et al. Among authors: berdugo m. JIMD Rep. 2023 Jan 29;64(2):161-166. doi: 10.1002/jmd2.12358. eCollection 2023 Mar. JIMD Rep. 2023. PMID: 36873092 Free PMC article.
86 results